GlobeNewswire

Positive Topline Results in Phase 2 STRIVE Parts A and B Clinical Trial

Positive Topline Results in Phase 2 STRIVE Parts A and B Clinical Trial

Rezafungin met its objectives for efficacy, safety and tolerability
Cidara Therapeutics, Inc.
Format

JPEG

Source

Cidara Therapeutics, Inc.

Téléchargements